385 related articles for article (PubMed ID: 10551276)
1. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking.
Hyytiä P; Ingman K; Soini SL; Laitinen JT; Korpi ER
Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):391-401. PubMed ID: 10551276
[TBL] [Abstract][Full Text] [Related]
2. Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake.
Barson JR; Carr AJ; Soun JE; Sobhani NC; Rada P; Leibowitz SF; Hoebel BG
Alcohol Clin Exp Res; 2010 Feb; 34(2):214-22. PubMed ID: 19951300
[TBL] [Abstract][Full Text] [Related]
3. Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats.
Honkanen A; Vilamo L; Wegelius K; Sarviharju M; Hyytiä P; Korpi ER
Eur J Pharmacol; 1996 May; 304(1-3):7-13. PubMed ID: 8813578
[TBL] [Abstract][Full Text] [Related]
4. Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors.
Korpi ER; Linden AM; Hytönen HR; Paasikoski N; Vashchinkina E; Dudek M; Herr DR; Hyytiä P
Addict Biol; 2017 Jul; 22(4):1022-1035. PubMed ID: 26990998
[TBL] [Abstract][Full Text] [Related]
5. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
Stoller DC; Sim-Selley LJ; Smith FL
Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
[TBL] [Abstract][Full Text] [Related]
6. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
Olianas MC; Concas D; Onali P
Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of spinal mu-opioid receptor function to activate G-protein by chronic naloxone treatment.
Narita M; Mizoguchi H; Nagase H; Suzuki T; Tseng LF
Brain Res; 2001 Sep; 913(2):170-3. PubMed ID: 11549382
[TBL] [Abstract][Full Text] [Related]
8. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
[TBL] [Abstract][Full Text] [Related]
9. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
Alcaraz C; Vargas ML; Milanés MV
Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
[TBL] [Abstract][Full Text] [Related]
10. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
11. Effects of morphine withdrawal on micro-opioid receptor-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate autoradiography in rat brain.
Kirschke C; Schadrack J; Zieglgänsberger W; Spanagel R
Eur J Pharmacol; 2002 Jun; 446(1-3):43-51. PubMed ID: 12098584
[TBL] [Abstract][Full Text] [Related]
12. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
13. Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology.
Millan MJ; Colpaert FC
Neuroscience; 1991; 42(2):541-53. PubMed ID: 1654538
[TBL] [Abstract][Full Text] [Related]
14. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion.
Ibuki T; Dunbar SA; Yaksh TL
Pain; 1997 Apr; 70(2-3):125-32. PubMed ID: 9150285
[TBL] [Abstract][Full Text] [Related]
15. Suppression of alcohol intake by chronic naloxone treatment in P rats: tolerance development and elevation of opiate receptor binding.
Overstreet DH; Kampov-Polevoy AB; Rezvani AH; Braun C; Bartus RT; Crews FT
Alcohol Clin Exp Res; 1999 Nov; 23(11):1761-71. PubMed ID: 10591592
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
[TBL] [Abstract][Full Text] [Related]
17. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
Millan MJ; Morris BJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
[TBL] [Abstract][Full Text] [Related]
18. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain.
Saland LC; Abeyta A; Frausto S; Raymond-Stintz M; Hastings CM; Carta M; Valenzuela CF; Savage DD
Alcohol Clin Exp Res; 2004 Jan; 28(1):98-104. PubMed ID: 14745307
[TBL] [Abstract][Full Text] [Related]
19. Further studies of opioids and intake of sweetened alcoholic beverage.
Hubbell CL; Abelson ML; Wild KD; Neuman R; Reid LD
Alcohol; 1988; 5(2):141-6. PubMed ID: 2840095
[TBL] [Abstract][Full Text] [Related]
20. Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys.
Chen L; Togasaki DM; Langston JW; Di Monte DA; Quik M
Neuroscience; 2005; 132(2):409-20. PubMed ID: 15802193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
